About Vertos Medical
Vertos Medical is a private company based in Aliso Viejo, California. It has reported $177,276,937 raised in 11 offerings on Form D since October 2009. Its chief executive is Eric Wichems.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 22, 2023 | Jun 6, 2023 | $44,557,631of $45.5M target | 29 | $1.5M | EquityRule 506(b) | Form D ↗ |
| May 6, 2021 | Nov 18, 2021 | $16,811,437of $17.0M target | 23 | $730K | Debt, OptionsRule 506(b) | Form D ↗ |
| Sep 17, 2019 | Sep 30, 2019 | $26,058,366of $27.5M target | 13 | $2.0M | Equity, OptionsRule 506(b) | Form D ↗ |
| Jun 7, 2017 | Jun 19, 2017 | $28,783,669of $28.8M target | 21 | $1.3M | EquityRule 506(b) | Form D ↗ |
| Dec 22, 2014 | May 12, 2015 | $5,971,186of $12.0M target | 21 | $284K | EquityRule 506(b) | Form D ↗ |
| Jun 17, 2013 | Jun 28, 2013 | $22,754,148fully sold | 63 | $361K | Equity06 | Form D ↗ |
| Apr 25, 2013 | May 2, 2013 | $1,800,000fully sold | 8 | $225K | Debt, Options, Securities on exercise06 | Form D ↗ |
| Dec 14, 2012 | Dec 27, 2012 | $2,052,644of $2.2M target | 10 | $205K | Debt, Options, Securities on exercise06 | Form D ↗ |
| Apr 26, 2012 | May 7, 2012 | $5,000,000fully sold | 6 | $833K | Debt, Options, Securities on exercise06 | Form D ↗ |
| May 13, 2011 | May 20, 2011 | $8,000,000fully sold | 7 | $1.1M | Equity06 | Form D ↗ |
| Oct 15, 2009 | Oct 27, 2009 | $15,487,856fully sold | 28 | $553K | Equity06 | Form D ↗ |
| Total, 11 offerings | $177,276,937 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Vertos Medical's Form D filed Jun 6, 2023.
Earlier filings also listed Robert Kuhling (director, last listed Nov 2021), Bruce Feuchter (secretary, last listed Nov 2021), John Ryan (director, last listed Jun 2017), Myles Greenberg (director, last listed May 2015), James Corbett (executive officer and director, last listed Jun 2013), Andrew Firlik (director, last listed Jun 2013), Daniel Watkins (director, last listed May 2013) and Harry Ross (director, last listed Oct 2009).